AK4 and nasopharyngeal carcinoma: In addition, AK4 was found to be significantly upregulated in chemoresistant patients compared with chemosensitive patients by reanalysis of our previous data [6] (Fig. 1H), suggesting a correlation between AK4 upregulation and the clinical response to IC in NPC.